Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Translated into:
Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Introduction to Mizrab-L Rabeprazole Levosulpiride Capsule
Mizrab-L Rabeprazole Levosulpiride Capsule is a combination medication used to treat gastrointestinal disorders such as gastroesophageal reflux disease (GERD), functional dyspepsia, and other conditions where acid suppression and gastric motility enhancement are beneficial. It combines Rabeprazole, a proton pump inhibitor (PPI), with Levosulpiride, a dopamine antagonist and prokinetic agent.
Uses of Mizrab-L Rabeprazole Levosulpiride Capsule
Managing gastroesophageal reflux disease (GERD)
Alleviating symptoms of functional dyspepsia
Improving gastric motility and reducing nausea
Treating gastric ulcers and acid-related disorders
Benefits of Mizrab-L Rabeprazole Levosulpiride Capsule
Dual Action: Combines acid suppression with enhanced gastric motility for comprehensive symptom relief.
Effective Acid Control: Rabeprazole reduces stomach acid production, relieving heartburn and acid reflux symptoms.
Enhanced Digestive Function: Levosulpiride improves gastric emptying and reduces nausea, promoting gastrointestinal comfort.
Versatile Use: Suitable for a range of acid-related and motility disorders of the gastrointestinal tract.
Mechanism of Action of Mizrab-L Rabeprazole Levosulpiride Capsule
Rabeprazole: Inhibits the proton pump in gastric parietal cells, thereby reducing acid secretion into the stomach.
Levosulpiride: Blocks dopamine receptors in the gastrointestinal tract, enhancing motility and improving gastric emptying.
Beside this well also export in other countries